PELI1 Targeting Advances CML Treatment
Targeting PELI1 in chronic myeloid leukaemia suppresses tumour growth, overcomes resistance, and eliminates stem cells, offering new therapeutic potential.
Targeting PELI1 in chronic myeloid leukaemia suppresses tumour growth, overcomes resistance, and eliminates stem cells, offering new therapeutic potential.